Australian children aged five to 11 could begin receiving the Pfizer vaccine by the end of November, with the nation’s regulator currently reviewing the health and safety data.

Pfizer submitted a partial application to Australia’s Therapeutic Goods Administration (TGA) last week and will supply the remaining data over the next two weeks. The TGA will then review all the information and make a decision about whether to approve the vaccine for use in this age group.